Fermented Mistletoe Extract as a Multimodal Antitumoral Agent in Gliomas

Tekijä Podlech, Oliver, Harter, Patrick N., Mittelbronn, Michel, Pöschel, Simone, Naumann, Ulrike
Julkaistu 2012

Cardiac Period 2 in myocardial ischemia: Clinical implications of a light dependent protein

Tekijä Bonney, Stephanie, Hughes, Kelly, Harter, Patrick N., Mittelbronn, Michel, Walker, Lori, Eckle, Tobias
Julkaistu 2013

Expression Profile of Sonic Hedgehog Pathway Members in the Developing Human Fetal Brain

Tekijä Tichy, Julia, Zinke, Jenny, Bunz, Benedikt, Meyermann, Richard, Harter, Patrick N., Mittelbronn, Michel
Julkaisussa Biomed Res Int (2015)

Mid-Gestation lethality of Atxn2l-Ablated Mice

Tekijä Key, Jana, Harter, Patrick N., Sen, Nesli-Ece, Gradhand, Elise, Auburger, Georg, Gispert, Suzana
Julkaisussa Int J Mol Sci (2020)

The pro-migratory and pro-invasive role of the procoagulant tissue factor in malignant gliomas

Tekijä Dützmann, Stephan, Gessler, Florian, Harter, Patrick N, Gerlach, Rüdiger, Mittelbronn, Michel, Seifert, Volker, Kögel, Donat
Julkaistu 2010

Podoplanin expression is a prognostic biomarker but may be dispensable for the malignancy of glioblastoma

Tekijä Eisemann, Tanja, Costa, Barbara, Harter, Patrick N, Wick, Wolfgang, Mittelbronn, Michel, Angel, Peter, Peterziel, Heike
Julkaisussa Neuro Oncol (2019)

ASA404, a vascular disrupting agent, as an experimental treatment approach for brain tumors

Tekijä Bähr, Oliver, Gross, Stefanie, Harter, Patrick N., Kirches, Elmar, Mawrin, Christian, Steinbach, Joachim P., Mittelbronn, Michel
Julkaisussa Oncol Lett (2017)

Cholinergic innervation and ganglion cell distribution in Hirschsprung’s disease

Tekijä Braczynski, Anne K., Gfroerer, Stefan, Beschorner, Rudi, Harter, Patrick N., Baumgarten, Peter, Rolle, Udo, Mittelbronn, Michel
Julkaisussa BMC Pediatr (2020)

Adora2b Signaling on Bone Marrow Derived Cells Dampens Myocardial Ischemia-Reperfusion Injury

Tekijä Koeppen, Michael, Harter, Patrick N., Bonney, Stephanie, Bonney, Megan, Reithel, Susan, Zachskorn, Cornelia, Mittelbronn, Michel, Eckle, Tobias
Julkaistu 2012

Ventriculoperitoneal Shunts Equipped with On-Off Valves for Intraventricular Therapies in Patients with Communicating Hydrocephalus due to Leptomeningeal Metastases

Tekijä Burger, Michael C., Wagner, Marlies, Franz, Kea, Harter, Patrick N., Bähr, Oliver, Steinbach, Joachim P., Senft, Christian
Julkaisussa J Clin Med (2018)

β-Catenin-Gli1 interaction regulates proliferation and tumor growth in medulloblastoma

Tekijä Zinke, Jenny, Schneider, Fabian T, Harter, Patrick N, Thom, Sonja, Ziegler, Nicole, Toftgård, Rune, Plate, Karl H, Liebner, Stefan
Julkaisussa Mol Cancer (2015)

Bevacizumab for Patients with Recurrent Multifocal Glioblastomas

Tekijä Burger, Michael C., Breuer, Stella, Cieplik, Hans C., Harter, Patrick N., Franz, Kea, Bähr, Oliver, Steinbach, Joachim P.
Julkaisussa Int J Mol Sci (2017)

Therapeutic Targeting of Stat3 Using Lipopolyplex Nanoparticle-Formulated siRNA in a Syngeneic Orthotopic Mouse Glioma Model

Tekijä Linder, Benedikt, Weirauch, Ulrike, Ewe, Alexander, Uhmann, Anja, Seifert, Volker, Mittelbronn, Michel, Harter, Patrick N., Aigner, Achim, Kögel, Donat
Julkaisussa Cancers (Basel) (2019)

Bevacizumab and radiotherapy for the treatment of glioblastoma: brothers in arms or unholy alliance?

Tekijä Niyazi, Maximilian, Harter, Patrick N., Hattingen, Elke, Rottler, Maya, von Baumgarten, Louisa, Proescholdt, Martin, Belka, Claus, Lauber, Kirsten, Mittelbronn, Michel
Julkaisussa Oncotarget (2015)

Increased tumor vascularization is associated with the amount of immune competent PD-1 positive cells in testicular germ cell tumors

Tekijä Jennewein, Lukas, Bartsch, Georg, Gust, Kilian, Kvasnicka, Hans-Michael, Haferkamp, Axel, Blaheta, Roman, Mittelbronn, Michel, Harter, Patrick N., Mani, Jens
Julkaisussa Oncol Lett (2018)

The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma

Tekijä Foltyn, Martha, Luger, Anna-Luisa, Lorenz, Nadja I., Sauer, Benedikt, Mittelbronn, Michel, Harter, Patrick N., Steinbach, Joachim P., Ronellenfitsch, Michael W.
Julkaisussa Br J Cancer (2019)

CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy

Tekijä Burger, Michael C., Zhang, Congcong, Harter, Patrick N., Romanski, Annette, Strassheimer, Florian, Senft, Christian, Tonn, Torsten, Steinbach, Joachim P., Wels, Winfried S.
Julkaisussa Front Immunol (2019)

MicroRNA-145 Targets the Metalloprotease ADAM17 and Is Suppressed in Renal Cell Carcinoma Patients

Tekijä Doberstein, Kai, Steinmeyer, Nico, Hartmetz, Ann-Kathrin, Eberhardt, Wolfgang, Mittelbronn, Michel, Harter, Patrick N, Juengel, Eva, Blaheta, Roman, Pfeilschifter, Josef, Gutwein, Paul
Julkaistu 2013

Downstream effects of plectin mutations in epidermolysis bullosa simplex with muscular dystrophy

Tekijä Winter, Lilli, Türk, Matthias, Harter, Patrick N., Mittelbronn, Michel, Kornblum, Cornelia, Norwood, Fiona, Jungbluth, Heinz, Thiel, Christian T., Schlötzer-Schrehardt, Ursula, Schröder, Rolf
Julkaisussa Acta Neuropathol Commun (2016)

Surgery for Glioblastoma in Light of Molecular Markers: Impact of Resection and MGMT Promoter Methylation in Newly Diagnosed IDH-1 Wild-Type Glioblastomas

Tekijä Gessler, Florian, Bernstock, Joshua D, Braczynski, Anne, Lescher, Stephanie, Baumgarten, Peter, Harter, Patrick N, Mittelbronn, Michel, Wu, Tianxia, Seifert, Volker, Senft, Christian
Julkaisussa Neurosurgery (2019)